Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 20.4B | 12.4B | 13.0B | 16.2B |
Cost of revenue | 17.6B | 10.1B | 10.5B | 15.2B |
Gross profit | 2.7B | 2.3B | 2.4B | 1.1B |
Operating expense | ||||
Research & development | 318.8M | — | — | 382.8M |
Selling general and admin | 442.0M | 1.6B | 1.5B | 55.8M |
Other operating expenses | 412.8M | — | — | -343.3M |
Operating income | 705.7M | 749.3M | 968.5M | 346.3M |
Non operating interest income | ||||
Income | 184.1M | — | — | 13.5M |
Expense | -117.7M | — | — | 195.8M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 567.2M | 1.3B | 565.0M |
Tax provision | -442.5M | -23.4M | -52.2M | 13.9M |
Net income | 2.1B | 590.6M | 1.3B | 551.1M |
Basic EPS | — | 59.3 | 120.7 | — |
Diluted EPS | — | 59.3 | 120.7 | — |
Basic average shares | — | 10.0M | 11.1M | — |
Diluted average shares | — | 10.0M | 11.1M | — |
EBITDA | 1.7B | 932.8M | 968.5M | 1.0B |
Net income from continuing op. | 2.1B | 549.7M | — | 551.1M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |